Next-generation CAR-T cell therapy against cancer: precision engineering, programmable immunity, and emerging clinical frontiers

Faizan-e- Mustaffa, Muhammad Shahbaz Aslam, Muhammad Junaid

Open source

DOI
10.1186/s43046-026-00415-1
Published
2026-09-29
Container
Journal of the Egyptian National Cancer Institute
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s43046-026-00415-1,
  title = {Next-generation CAR-T cell therapy against cancer: precision engineering, programmable immunity, and emerging clinical frontiers},
  author = {Faizan-e- Mustaffa and Muhammad Shahbaz Aslam and Muhammad Junaid},
  year = {2026},
  journal = {Journal of the Egyptian National Cancer Institute},
  doi = {10.1186/s43046-026-00415-1},
  url = {https://doi.org/10.1186/s43046-026-00415-1}
}

RIS

TY  - JOUR
TI  - Next-generation CAR-T cell therapy against cancer: precision engineering, programmable immunity, and emerging clinical frontiers
AU  - Faizan-e- Mustaffa
AU  - Muhammad Shahbaz Aslam
AU  - Muhammad Junaid
PY  - 2026
JO  - Journal of the Egyptian National Cancer Institute
DO  - 10.1186/s43046-026-00415-1
UR  - https://doi.org/10.1186/s43046-026-00415-1
ER  - 

APA

Mustaffa, F., Aslam, M. S., & Junaid, M. (2026). Next-generation CAR-T cell therapy against cancer: precision engineering, programmable immunity, and emerging clinical frontiers. Journal of the Egyptian National Cancer Institute. https://doi.org/10.1186/s43046-026-00415-1

Source records